Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Yang

Showing results (741-750 of 839) with videos related to

Pageof 84
Sort By:
Frontiers in Public Health|December 10, 2021
Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019Ying Wu, Ping Song, Shuai Lin, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|July 12, 2012
[Biologic effect of nitric oxide on human epidermal stem cells in vitro]Ri-xing Zhan, Wei Sun, Zhi-hui Yao, et al.
Cancer Cell|October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patientsYi Pan, Jia-Tao Zhang, Xuan Gao, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Scientific Reports|December 10, 2014
Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cellsMing-Da Zhou, Sijie Hao, Anthony J Williams, et al.
Frontiers in Immunology|May 2, 2024
A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistanceMeng-Yao Xu, Zhi-Yu Xia, Jian-Xuan Sun, et al.
Clinical and Translational Medicine|June 9, 2020
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR-TKIs in EGFR-mutant advanced NSCLC than BIM deletion polymorphismSi-Yang Liu, Jia-Ying Zhou, Wen-Feng Li, et al.
Therapeutic Advances in Medical Oncology|March 30, 2019
Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?Ji-Jin Yao, Ya-Nan Jin, Zhi-Gang Liu, et al.
Annals of Surgical Oncology|November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic AdenocarcinomaAsmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
Clinical Lung Cancer|October 18, 2024
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R MutationQing Zhou, Jie Li, Shun-Dong Cang, et al.
Pageof 84

Showing results (741-750 of 839) with videos related to

Sort By:
Pageof 84
Frontiers in Public Health|December 10, 2021
Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019Ying Wu, Ping Song, Shuai Lin, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|July 12, 2012
[Biologic effect of nitric oxide on human epidermal stem cells in vitro]Ri-xing Zhan, Wei Sun, Zhi-hui Yao, et al.
Cancer Cell|October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patientsYi Pan, Jia-Tao Zhang, Xuan Gao, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Scientific Reports|December 10, 2014
Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cellsMing-Da Zhou, Sijie Hao, Anthony J Williams, et al.
Frontiers in Immunology|May 2, 2024
A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistanceMeng-Yao Xu, Zhi-Yu Xia, Jian-Xuan Sun, et al.
Clinical and Translational Medicine|June 9, 2020
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR-TKIs in EGFR-mutant advanced NSCLC than BIM deletion polymorphismSi-Yang Liu, Jia-Ying Zhou, Wen-Feng Li, et al.
Therapeutic Advances in Medical Oncology|March 30, 2019
Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?Ji-Jin Yao, Ya-Nan Jin, Zhi-Gang Liu, et al.
Annals of Surgical Oncology|November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic AdenocarcinomaAsmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
Clinical Lung Cancer|October 18, 2024
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R MutationQing Zhou, Jie Li, Shun-Dong Cang, et al.
Pageof 84